Updates are available New edition dated 2024-07-15

Click to view New edition: https://doi.org/10.29328/journal.acst.1001043

Durable Response to Pembrolizumab and Lenvatinib in a Patient with Chemotherapy-refractory Cholangiocarcinoma

Crossref DOI link: https://doi.org/10.29328/journal.acst.1001043

Published Online: 2024-07-15

Published Print: 2024-07-15

Update policy: https://doi.org/10.29328/crossmark-policy

About CrossMark